Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 Duration in Stage II Gastric Cancer (SMAC)
NCT03941561Phase 3Recruiting
- Sponsor
- Fudan University
- Start
- Jan 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegafur in gastric cancer (GC), sponsored by Fudan University. Started Jan 2019; status: recruiting.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT03941561.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03941561.